Pierre Wauthy
12
0
0
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Evaluation of Hemodynamic Changes of the Left Ventricle Following the Use of Extracorporeal Circulation
Role: lead
Development of a Quality of Life Assessment Tool for Adult Patients With a Congenital Heart Disease, Having Had Surgery During Childhood
Role: lead
Post-Surgical Mediastinitis Within the CHU Brugmann Hospital
Role: lead
Considerations on the Transfusion Threshold in Cardiac Surgery
Role: lead
Eligibility Criteria for Cholecystectomy in Ambulatory Surgery
Role: lead
Cardiac Resynchronization Therapy: Relevance of the Surgical Approach in the Implantation of the Left Ventricular Probe
Role: lead
Evolution of Two Cohorts of Children (Univentricular and Bi-ventricular Heart) After Strapping of the Pulmonary Artery
Role: lead
Study of Gastro-oesophageal Reflux in Patients Having Had Bariatric Surgery
Role: lead
Morbimortality of Contegra Duct Replacements Versus Homografts in Pulmonary Position
Role: lead
Long-term Quality of Life of Patients With a Congenital Heart Disease, Treated by Surgery in Adulthood at the Brugmann Hospital.
Role: lead
Comparative Study of Survival and Long-term Quality of Life After Cardiac Surgery in Patients Who Are Jehovah's Witnesses
Role: lead
Study on the Transfusional Management of the Patients With Congenital Heart Disease Carried Out in Adulthood.
Role: lead
All 12 trials loaded